| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Johnson Craig A serves as a Director at HRTX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 4 sells. Those positions are worth an estimated $229K at current prices.
Historically, Johnson Craig A's trades have earned a strong insider score of 79/100 across 4 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +70.1%.
The biggest single holding is AUPH (~$229K) as Director.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 21, 2021 | HRTX Heron Therapeutics, Inc. /de/ | Director | Sell | 250 | $9.73 | $2,431.93 | -8.1% | -47.0% | -72.2% | |
| Sep 21, 2021 | HRTX Heron Therapeutics, Inc. /de/ | Director | Sell | 250 | $12.30 | $3,074.10 | -7.5% | -20.3% | -64.7% | |
| Jun 21, 2021 | HRTX Heron Therapeutics, Inc. /de/ | Director | Sell | 250 | $15.20 | $3,800.60 | -7.0% | -21.1% | -81.2% | |
| Apr 6, 2021 | HRTX Heron Therapeutics, Inc. /de/ | Director | Sell | 250 | $17.22 | $4,305.20 | -6.5% | -14.0% | -62.5% |